Comprehensive digital platform brings both clinical and educational material regarding home dialysis together, creating a powerful resource for UK healthcare professionals and patients
LONDON, Sept. 17, 2018 /PRNewswire/ -- NxStage Medical, Inc. (Nasdaq: NXTM), a leading medical technology company focused on advancing renal care, today announced the launch of its new UK website. The comprehensive website brings both clinical and educational material regarding home dialysis together in one location creating an invaluable resource for UK healthcare professionals and patients.
The new website features a streamlined and simplified design, improved functionality and rich content areas focused on kidney disease, clinical data and home dialysis. For healthcare professionals, the website provides clinical data, information on the use of NxStage products, and guides for implementing best practices in home haemodialysis. For patients, the website offers educational information regarding kidney disease, treatment modalities, advice for speaking with doctors, and insightful stories from patients that have benefitted from home haemodialysis and more frequent therapy.
"We've refined our website to make it easier to access relevant clinical and educational material regarding home dialysis," stated Matt Walker, NxStage Medical UK, Ltd. "With a growing number of people needing dialysis in the UK, this new resource demonstrates our continuing commitment to increasing awareness and education about the life-changing benefits possible with home haemodialysis."
The new website can be found at: https://www.nxstage.co.uk/
For more information contact:
Katie Elliott / firstname.lastname@example.org / 0203 6965800
About NxStage Medical
NxStage Medical, Inc. (Nasdaq: NXTM) is a leading medical technology company, headquartered in the United States, that develops, manufactures and markets innovative products for the treatment of end-stage renal disease (ESRD) and acute kidney failure. For more information on NxStage and its products and services, please visit https://www.nxstage.co.uk/.
This release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this release that are not clearly historical in nature are forward-looking, and the words "anticipate," "believe," "expect," "estimate," "plan," and similar expressions are generally intended to identify forward-looking statements. Actual results may differ materially from those indicated by these forward-looking statements as a result of various important factors including those that are discussed in NxStage's filings with the Securities and Exchange Commission, including its Quarterly Report on Form 10-Q for the quarter ended June 30, 2018. NxStage is under no obligation to (and expressly disclaims any such obligation to) update or alter its forward-looking statements, whether as a result of new information, future events or otherwise.
SOURCE NxStage Medical, Inc.